Project Grant R21AI199669
Award Date 6/23/26
Completion Date 5/31/28
Dollars Obligated $249K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- Federal Project Grant Award Summary Award Overview The National Institute of Allergy and Infectious Diseases (NIAID) awarded Emory University a Project Grant of $954,603 on April 9, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research and development activities extending through March 31, 2028, conducted at Emory's Atlanta, Georgia location. Research Deliverables The grant supports the development of a novel long-acting injectable...
- Federal Grant Award Summary Award Overview: Emory University's Office of Sponsored Programs received a $234,156 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 28, 2026, with completion targeted for October 31, 2028. The award funds research conducted in Atlanta, Georgia. Research Products and Services: The grant supports fundamental research on capsid assembly...
- Federal Project Grant Summary Emory University received a $273,000 exploratory project grant awarded May 8, 2026, through the National Institute of Allergy and Infectious Diseases (NIAID) Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research investigating the role of B cells and antibody responses in virus-induced hepatocellular carcinoma (HCC) using a physiological rodent model of chronic hepaciviral infection. The primary deliverables include establishment...
- Federal Project Grant Award Summary Emory University received a $909,998 project grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 5, 2026, with completion targeted for January 31, 2031. The research focuses on characterizing an antiretroviral drug therapy (ART)-free approach to establishing a simian immunodeficiency virus (SIV) reservoir through antibody-mediated mechanisms. The...
- Federal Project Grant Award Summary Emory University received a $909,998 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded May 5, 2026, with completion targeted for April 30, 2031. The project aims to develop an innovative HIV vaccination strategy utilizing DNA-lipid nanoparticle (DNA-LNP) technology to induce strong and durable cellular and humoral immunity against HIV. The...
- Federal Project Grant Award Summary Emory University received a $160,448 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded March 10, 2026, with completion targeted for September 10, 2028. The research will generate scientific products addressing antiviral resistance to acyclic phosphonates in orthopoxviruses, specifically monkeypox virus (MPXV). The project will deliver three...
- Federal Grant Award Summary Emory University received a $2,297,892 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 17, 2025, with completion targeted for June 30, 2029. The award funds a four-year research investigation into the mechanisms by which interferon-induced transmembrane proteins (IFITMs) inhibit viral membrane fusion and restrict diverse enveloped viruses...
- Federal Project Grant Award Summary Emory University's Office of Sponsored Programs received a $430,375 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, with completion scheduled for July 31, 2027. The award funds investigator-initiated biomedical research examining inter-membrane lipid signaling mechanisms in gram-negative bacteria, specifically focusing on...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Rockefeller University $862,748 through the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 23, 2026, to support research on elucidating host and viral determinants of treatment response in chronic Hepatitis B virus (HBV) infection. The five-year project, scheduled for completion on January 31, 2031, focuses on understanding the biological mechanisms that...
- Federal Grant Award Summary HBVTech, LLC received a $258,750 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of September 1, 2025, and completion target of August 31, 2026. The grant supports the development of HBVZ10, a novel gene therapy candidate designed to cure chronic hepatitis B virus (HBV) infection. HBVZ10 utilizes an optimized adeno-associated virus serotype...